Merilog will be provided by prefilled pen in a 3 mL dose or in a multiple-dose 10 mL vial. It is for adults ... a planned 75% reduction in the cost of NovoLog. Then a few days later, Sanofi ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog ... mL single-patient-use prefilled pen and 10 mL multiple-dose ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog ... mL single-patient-use prefilled pen and a 10-mL multiple-dose vial ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting ... The FDA has approved 65 biosimilar products to date. Like Novolog, Merilog should be administered within ...

WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog ... and a 10-mL multiple-dose vial are ...